Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | FDPS | P14324 | 1/20 | 0.32 |
| ▸ | ADH1B | P00325 | 3/20 | 0.32 |
| ▸ | ADH1C | P00326 | 3/20 | 0.32 |
| ▸ | ADH1A | P07327 | 3/20 | 0.32 |
| ▸ | ADH7 | P40394 | 3/20 | 0.32 |
| ▸ | ADH4 | P08319 | 2/20 | 0.31 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.31 |
| ▸ | ESR1 | P03372 | 1/20 | 0.30 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.30 |
| ▸ | FAAH | O00519 | 2/20 | 0.30 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5138900 | 0.93 | TSHR (0.37) | TSHRSMN1; SMN2FDPSADH1BADH1C | |
| SCHEMBL6798591 | 0.91 | TSHR (0.41) | TSHRFDPSADH1BADH1CADH1A | |
| SCHEMBL6797613 | 0.91 | TSHR (0.41) | TSHRFDPSADH1BADH1CADH1A | |
| SCHEMBL6792415 | 0.91 | TSHR (0.41) | TSHRFDPSADH1BADH1CADH1A | |
| SCHEMBL6796097 | 0.91 | TSHR (0.41) | TSHRFDPSADH1BADH1CADH1A | |
| SCHEMBL6797179 | 0.91 | TSHR (0.41) | TSHRFDPSADH1BADH1CADH1A | |
| SCHEMBL9171978 | 0.90 | TSHR (0.39) | TSHRSMN1; SMN2FDPSADH1BADH1C | |
| SCHEMBL9245830 | 0.85 | TSHR (0.39) | TSHRSMN1; SMN2FDPSADH1BADH1C | |
| SCHEMBL5137670 | 0.85 | TSHR (0.36) | TSHRSMN1; SMN2FDPSADH1BADH1C | |
| SCHEMBL2009418 | 0.84 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2016038070-A1 | COATING COMPOSITION FOR WOOD FINISHING | SHERWIN-WILLIAMS DEUTSCHLAND GMBH (DE) | 2016-03-17 | — | — | WO | claimed |
| EP-0018342-B1 | NOVEL DERIVATIVES OF GLYCERIN, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | SANOFI S.A. (FR) | 1983-02-16 | — | — | EP | claimed |
| CN-106457273-B | Flush dispenser for delivering a consistent consumer experience | 宝洁公司 | 2019-05-07 | — | — | CN | disclosed |
| CN-107921453-A | For distributing the distributor of microcapsules | 宝洁公司 | 2018-04-17 | — | — | CN | disclosed |
| CN-107922882-A | Perfume mixture | 西姆莱斯股份公司 | 2018-04-17 | — | — | CN | disclosed |
| EP-2939996-B1 | GROUP 5 METAL OXO-ALKOXO COMPLEX, METHOD FOR PRODUCING SAME, AND METHOD FOR MANUFACTURING GROUP 5 METAL OXIDE FILM | TOSOH CORP (JP) | 2018-03-21 | — | — | EP | disclosed |
| CN-107249545-A | Composition providing delayed release of active substances | 诺赛尔股份有限公司 | 2017-10-13 | — | — | CN | disclosed |
| CN-107107019-A | It is coated microcapsules | 宝洁公司 | 2017-08-29 | — | — | CN | disclosed |
| CN-107001979-A | Coated microcapsules | 宝洁公司 | 2017-08-01 | — | — | CN | disclosed |
| CN-106999896-A | Coated microcapsules | 宝洁公司 | 2017-08-01 | — | — | CN | disclosed |
| CN-106999895-A | It is coated microcapsules | 宝洁公司 | 2017-08-01 | — | — | CN | disclosed |
| US-7351841-B2 | Heterocyclic compounds and thrombopoietin receptor activators | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2008-04-01 | — | — | US | disclosed |
| US-20080027068-A1 | HETEROCYCLIC COMPOUNDS AND THROMBOPOIETIN RECEPTOR ACTIVATORS | NISSAN CHEMICAL INDUSTRIES LIMITED (JP) | 2008-01-31 | — | — | US | disclosed |
| EP-1845090-A1 | AMIDE COMPOUND AND THROMBOPOIETIN RECEPTOR ACTIVATOR | Nissan Chemical Industries, Ltd. (JP) | 2007-10-17 | — | — | EP | disclosed |
| CN-1798739-A | 3-alkylidenehydrazino substituted heteroaryl compounds as thrombopoietin receptor activators | NISSAN CHEMICAL IND LTD (JP) | 2006-07-05 | — | — | CN | disclosed |
| US-20060094694-A1 | Heterocyclic compounds and thrombopoietin receptor activators | NISSAN CHEMICAL INDUSTRIES LIMITED (JP) | 2006-05-04 | — | — | US | disclosed |
| EP-0492847-B2 | Air curing polymer composition | ROHM & HAAS (US) | 2002-11-20 | — | — | EP | disclosed |
| EP-0381040-B1 | METHOD FOR THE PREPARATION OF 2,2-DIALKYLPROPIONALDEHYDES | BASF Aktiengesellschaft (DE) | 1993-03-31 | — | — | EP | disclosed |
| US-5012006-A | Hydroformylation of 1,1-dialkylethylenes in presence of cobalt carbonyl complex catalysts, water-containing solvents or lactones or sulfones | BASF AKTIENGESELLSCHAFT (DE) | 1991-04-30 | — | — | US | disclosed |
| EP-0381040-A2 | Method for the preparation of 2,2-dialkylpropionaldehydes | BASF Aktiengesellschaft (DE) | 1990-08-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060094694-A1 | Heterocyclic compounds and thrombopoietin receptor activators | NR2C2, ROR1, NR0B2 | TSHR 47/4885SMN1; SMN2 2170/4885FDPS 3051/4885 |
| US-20080027068-A1 | HETEROCYCLIC COMPOUNDS AND THROMBOPOIETIN RECEPTOR ACTIVATORS | NR2C2, ROR1, NR0B2 | TSHR 44/4885SMN1; SMN2 1967/4885FDPS 3141/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.